Role of testosterone and its metabolites on different physiological functions in subjects affected by gender identity disorde GID FtM transsexuals

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-004872-11-IT

Enrollment

Registered

2007-02-12

Start date

2005-01-28

Completion date

Unknown

Last updated

2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maintenance of the characteristics and functions androgen-employee in FtM subjects after participation of RCS isteroannessiectomia. MedDRA version: 6.1 Level: PT Classification code 10044337

Interventions

Trade Name: Nebido Pharmaceutical Form: Solution for injection INN or Proposed INN: Testosterone Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 1000- Trade Name:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026